QualityStocksNewsBreaks Archives - Page 11 of 1367

FridayMar 21, 2025 11:50 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Announces Key Milestones and 2024 Financial Results

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced its recent accomplishments and financial results for the year ended Dec. 31, 2024. “We remain highly focused on advancing our multiple clinical programs as we work towards achieving a number of important and potentially transformational development milestones, including top-line results in 2026 for our actively enrolling confirmatory Phase 3 placebo-controlled study evaluating HyBryte(TM) (synthetic hypericin) in the treatment of early-stage cutaneous T-cell lymphoma (‘CTCL’),” stated Christopher J. Schaber, PhD, president and chief executive officer…

FridayMar 21, 2025 10:17 am

QualityStocksNewsBreaks – General Mills, Inc. (NYSE: GIS) Reports Mixed Q3 2025 Results, Updates Outlook

General Mills (NYSE: GIS) announced its third-quarter fiscal 2025 results, reporting earnings per share (“EPS”) of $1.00, surpassing analyst expectations of $0.98. However, revenue fell short, totaling $4.8 billion against a projected $4.99 billion. The company attributed the revenue miss to greater-than-expected retailer inventory headwinds and a slowdown in U.S. snacking categories. In response, General Mills plans to invest in consumer value, media support, and in-store visibility in the fourth quarter to drive growth. To view the full article, visit https://ibn.fm/xH2Wq About General Mills General Mills makes food the world loves. The company is guided by its Accelerate strategy to…

ThursdayMar 20, 2025 11:00 am

QualityStocksNewsBreaks – Apple Inc. (NASDAQ: AAPL) Loses Top Health Executive to Oura, Fueling Smart Ring Market Growth

Apple (NASDAQ: AAPL) has lost a key executive from its health division, as Dr. Ricky Bloomfield, formerly the Clinical and Health Informatics Lead, departs to join Oura as its Chief Medical Officer. Bloomfield played a critical role in shaping Apple’s health strategy, including its push into digital health records and wearable health tracking. His move to Oura, a company specializing in smart rings for health monitoring, signals growing competition in the wearable health-tech space, with some analysts seeing it as a potential shift in consumer interest toward ring-based health tracking over smartwatches. As of the latest trading session, Apple’s stock is…

ThursdayMar 20, 2025 10:50 am

QualityStocksNewsBreaks – Match Group Inc. (NASDAQ: MTCH) Faces Proxy Battle as Anson Funds Seeks Board Changes

Match Group (NASDAQ: MTCH), s confronting a proxy challenge from hedge fund Anson Funds, which plans to nominate directors to the company’s 10-member board. Anson, holding approximately 0.6% of Match Group’s shares as of December, has been advocating for over a year for the parent company of Tinder, Hinge, and OkCupid to reassess capital allocation, reduce costs, and evaluate its MG Asia business. The hedge fund has also expressed concerns about corporate governance and executive turnover, noting that Match Group has had four CEOs in five years. As of 10:30 AM EDT on March 20, 2025, Match Group’s stock is…

ThursdayMar 20, 2025 9:35 am

QualityStocksNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Acquires Genetic Networks in $10 Million Stock Deal

Fifty 1 Labs (OTC: FITY) a holding company in the health, wellness, and biotech sectors, has acquired Genetic Networks LLC, a biotech firm founded by Dr. Gennaro D’Urso, for $10 million in common shares. As part of the deal, Dr. D’Urso has been appointed CEO and Chairman, while Brandon Spikes remains President and Director. Genetic Networks, known for its GeneScape™ platform, is actively negotiating multi-million dollar contracts with the U.S. Department of Defense to develop biothreat countermeasures. The acquisition enhances FITY’s biotech capabilities, positioning it for rapid growth in personalized medicine, drug repurposing, and biodefense solutions. To view the full press…

ThursdayMar 20, 2025 8:30 am

QualityStocksNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Identifies Rhodonite at Montauban, Signaling Potential for Deeper High-Grade Mineralization

ESGold (CSE: ESAU) (OTCQB: ESAUF) has identified rhodonite at its Montauban Project, a manganese-rich mineral often associated with Broken Hill-type deposits. The discovery suggests that structurally controlled deformation and remobilization may have influenced mineralization at depth, enhancing the potential for high-grade lead, zinc, silver, and gold zones. This finding supports ESGold’s geological model and adds significance to its ongoing Ambient Noise Tomography survey, which is aimed at defining deeper, previously untested mineralized structures. To view the full press release, visit https://ibn.fm/35DqE About ESGold Corp. ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) is a fully permitted, pre-production resource company at the forefront…

ThursdayMar 20, 2025 8:30 am

QualityStocksNewsBreaks – Capstone Holding Corp. (NASDAQ: CAPS) Offsets Tariffs with Lower Freight Costs, Eyes Strong 2025

Capstone Holding Corp. (NASDAQ: CAPS), a building products holding company expanding through acquisition and organic growth, reported that while tariffs on goods imported from China have increased due to presidential orders, container shipping rates from China to the U.S. have dropped 15% to 25% since the start of the year. This decline has largely neutralized the tariff impact, with customers seeing only modest price increases. Company leadership expects continued momentum into 2025, citing resilient supply chains and favorable housing trends. To view the full press release, visit https://ibn.fm/29fTX About Capstone Holding Corp. Capstone Holding Corp. is a building products distribution…

WednesdayMar 19, 2025 2:11 pm

QualityStocksNewsBreaks – Adageis Navigates Complexities of Value-Based Care with Tailored Solution

Adageis was featured in a recent article that discussed the company’s positioning as healthcare shifts toward value-based care, where providers are reimbursed for patient outcomes rather than the number of procedures performed. “While the model promises higher-quality care at lower costs, it also introduces complex reimbursement structures that can be difficult to navigate,” the article reads. “One of the major challenges in the marketplace is the sheer complexity… Adageis has a solution that integrates with nearly 100 electronic health record systems, overlaying existing platforms to provide easy-to-read measures tailored to each patient’s insurance,” Adageis CEO Shane Speirs was quoted as saying.…

WednesdayMar 19, 2025 1:18 pm

QualityStocksNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Fuels Explosive Growth with Disruptive AdTech Platform

Thumzup (NASDAQ: TZUP) is leveraging its proprietary social media marketing platform, AdTech, which drives influencers to catapult the effectiveness of small-business advertising. Having achieved a growth rate of over 200% CAGR, Thumzup now serves more than 700 clients, with projections to exceed 1,000 by the next financial quarter. As social media marketing continues to grow, Thumzup’s innovative platform allows brands to easily customize campaigns and incentivizes influencer engagement with direct cash rewards, making it a disruptive force in the industry. CEO Robert Steele attributed the company’s growth as a testament to the effectiveness of its model, stating, “Our rapid growth to…

TuesdayMar 18, 2025 12:41 pm

QualityStocksNewsBreaks – Why Soligenix Inc. (NASDAQ: SNGX) Is ‘One to Watch’

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. “Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases,” reads a recent article. “With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.” To view the full article, visit https://ibn.fm/B722I About Soligenix Inc. Soligenix is a late-stage biopharmaceutical company focused on developing…

Site Search

Company Search

Category: QualityStocksNewsBreaks